PGgRC  have not approved this publication yet,  pending getting an opinion from our patent attorneys on whether this publication  would prejudice our patent applications we have commenced developing to support the commercialisation of the Vaccine. I would hope that this response will enable any  timing or changes in content to be identified so that the publication can be submitted. 

1/12/14  With the update text The PGGRC approves the publication for submission. Thank you to the authors for their cooperation in this matter. 